Latest On Assembly Biosciences, Inc (ASMB):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-04 22:29 EST | News | Assembly Biosciences GAAP EPS of -$0.37 | N/A |  |
| 2023-03-22 23:50 EST | News | Assembly Biosciences GAAP EPS of -$1.92 in-line | N/A | |
| 2022-12-19 15:05 EST | News | Assembly Biosciences surges 19% on positive data from two trials to treat hepatitis B virus | N/A | |
| 2022-11-09 02:35 EST | News | Assembly Biosciences GAAP EPS of -$0.48 beats by $0.06 | N/A | |
| 2022-10-24 18:54 EST | News | Assembly Biosciences downgraded at Truist on trial failure, lack of catalysts | N/A | |
| 2022-10-05 18:32 EST | News | Jason Okazaki to succeed John McHutchison as Assembly Biosciences CEO at year-end | N/A | |
| 2022-08-09 18:57 EST | News | Assembly Biosciences GAAP EPS of -$0.51 | N/A | |
| 2022-07-20 18:51 EST | News | Assembly Biosciences to discontinue development of inhibitor vebicorvir, cut workforce | N/A | |
| 2022-05-13 07:30 EST | News | Assembly Biosciences GAAP EPS of -$0.48 | N/A | |
| 2022-03-11 07:35 EST | News | Assembly Biosciences GAAP EPS of -$3.00 misses by $0.90, revenue of $6.25M beats by $0.09M | N/A | |
| 2021-11-05 01:28 EST | News | Assembly Biosciences EPS beats by $0.15 | N/A | |
| 2021-10-20 02:57 EST | News | Assembly Biosciences and Antios ink clinical collaboration agreement | N/A | |
| 2021-09-01 19:23 EST | News | Assembly Bio abandons development of phase 2 hepatitis b candidate; shares down 13% | N/A | |
| 2021-08-05 22:21 EST | News | Assembly Biosciences EPS beats by $0.11 | N/A | |
| 2021-08-04 03:06 EST | News | Assembly Biosciences makes COO and CFO promotions | N/A | |
| 2021-07-20 20:00 EST | News | Assembly Biosciences announces resignation of CFO | N/A | |
| 2021-07-20 19:49 EST | News | Assembly Bio presents data from HBV core inhibitor programs at EASL 2021 | N/A | |
| 2021-05-07 03:59 EST | News | Assembly Biosciences EPS beats by $0.10 | N/A | |
| 2021-03-03 15:07 EST | Analyst Rating | The Analyst Target Price has decreased from $17.6 to $11.6. | Neutral | |
| 2021-03-02 07:09 EST | Analyst Rating | The Analyst Target Price has decreased from $17.8 to $17.6. | Neutral | |
| 2021-03-01 15:07 EST | Earnings Estimate | An EPS average of -$3.32 is estimated for the 2022 year. | Sell | |
| 2021-03-01 15:07 EST | Earnings Estimate | An EPS average of -$0.76 is estimated for the quarter ending on June 30, 2021. | Buy | |
| 2021-03-01 15:07 EST | Analyst Rating | The Analyst Target Price has decreased from $18.6 to $17.8. | Neutral | |
| 2021-02-28 20:13 EST | News | Assembly Biosciences, Inc. (ASMB) CEO on Hepatitis B Program Update Call Transcript | N/A | |
| 2021-02-26 15:24 EST | News | Assembly Bio, Arbutus Bio commence trial of triple combo therapy in hepatitis B | N/A | |
| 2021-02-26 15:07 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-25 20:03 EST | News | Assembly Biosciences scraps Phase 3 vebicorvir study plans | N/A | |
| 2021-02-25 20:03 EST | News | Assembly Biosciences EPS misses by $0.19, misses on revenue | N/A | |
| 2020-12-22 11:09 EST | Analyst Rating | The Analyst Target Price has decreased from $19.2 to $18.6. | Neutral | |
| 2020-12-13 03:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-08 20:20 EST | News | Assembly Biosciences pulls the plug on microbiome program | N/A | |
| 2020-12-07 11:09 EST | Analyst Rating | The Analyst Target Price has decreased from $22.6 to $19.2. | Neutral | |
| 2020-11-17 02:37 EST | News | Assembly Bio inks deal with Door Pharmaceuticals to develop HBV core protein modulators | N/A | |
| 2020-11-15 11:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-09 03:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 23:09 EST | Analyst Rating | The Analyst Target Price has decreased from $45.4 to $22.6. | Neutral | |
| 2020-11-07 03:32 EST | News | Assembly Bio plunges on disappointing vebicorvir data in HBV infection study | N/A | |
| 2020-11-06 11:10 EST | Earnings Estimate | An EPS average of -$0.67 is estimated for the quarter ending on March 31, 2021. | Sell | |
| 2020-11-06 02:49 EST | News | Assembly Biosciences EPS beats by $0.69, beats on revenue | N/A | |
| 2020-11-01 17:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-30 12:13 EST | Analyst Rating | The Analyst Target Price has increased from $43 to $45.4. | Buy | |
| 2020-09-26 04:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-10 18:35 EST | News | Assembly Biosciences (ASMB) Investor Presentation - Slideshow | N/A | |
| 2020-08-28 19:29 EST | News | Assembly Bio HBV core inhibitors show positive action in studies | N/A | |
| 2020-08-28 19:29 EST | News | Assembly Bio files for $300M mixed shelf | N/A | |
| 2020-08-27 12:49 EST | News | Assembly Biosciences teams up with Arbutus Biopharma in chronic HBV infection | N/A | |
| 2020-08-15 17:17 EST | News | Stocks To Watch: Walmart, Target, Kandi And Gold vs. Bitcoin | N/A | |
| 2020-08-10 16:47 EST | Insider Trade | John G McHutchison has directly disposed of 756 shares and currently holds 137,849 shares. | Sell | |
| 2020-08-10 16:47 EST | Insider Trade | John G McHutchison has directly disposed of 11,395 shares and currently holds 138,605 shares. | Sell | |
| 2020-08-07 00:11 EST | Financials | Company financials have been released. | Neutral | |
About Assembly Biosciences, Inc (ASMB):
Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H2158, which is in Phase II clinical study for chronic HBV infection; ABI-H3733 that has completed Phase Ia clinical study for the treatment of HBV. The company has collaboration agreements with Allergan Pharmaceuticals International Limited; BeiGene, Ltd.; and Arbutus Biopharma Corporation, as well as strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in South San Francisco, California.
General
- Name Assembly Biosciences, Inc
- Symbol ASMB
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 139
- Last Split Factor1:5
- Last Split Date2014-07-14
- Fiscal Year EndDecember
- IPO Date2010-12-17
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryPharmaceuticals
- Web URLhttp://www.assemblybio.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 2.17
- Price/Book (Most Recent Quarter) 0.77
- Enterprise Value Revenue 5.85
- Enterprise Value EBITDA 0.33
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$3.15
- Next Year EPS Estimate -$2.88
- Next Quarter EPS Estimate -$0.76
- Profit Margin -79%
- Operating Margin -77%
- Return on Assets -12%
- Return on Equity -24%
- Revenue 79.11 million
- Earnings Per Share -$3.66
- Revenue Per Share $2.23
- Gross Profit -22232000
- Quarterly Earnings Growth -78.2%
View More
Highlights
- Market Capitalization 185.11 million
- EBITDA -99942000
- Analyst Target Price $11.6
- Book Value Per Share $7.07
View More
Share Statistics
- Shares Outstanding 38.25 million
- Shares Float 33.7 million
- % Held by Insiders 465%
- % Held by Institutions 94.26%
- Shares Short 3.87 million
- Shares Short Prior Month 2.49 million
- Short Ratio 2.28
- Short % of Float 10%
- Short % of Shares Outstanding 10%
View More
Technicals
- Beta 0.42
- 52 Week High $27.84
- 52 Week Low $4.31
- 50 Day Moving Average 5.55
- 200 Day Moving Average 9.54
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Assembly Biosciences, Inc (ASMB) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Assembly Biosciences, Inc (ASMB) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-25 | $N/A | -$1.11 | -$0.90 | -22.79% |
| 2020-09-30 | 2020-11-05 | $N/A | -$0.09 | -$0.78 | 88.46% |
| 2020-06-30 | 2020-08-05 | $N/A | $0.19 | $0.22 | -14.91% |
| 2020-03-31 | 2020-05-08 | $N/A | -$0.76 | -$0.98 | 22.45% |
| 2019-12-31 | 2020-03-04 | $4.77 million | -$0.99 | -$1.01 | 1.74% |
| 2019-09-30 | 2019-11-07 | $4.23 million | -$0.96 | -$0.93 | -3.23% |
| 2019-06-30 | 2019-08-05 | $3.08 million | -$0.72 | -$1.15 | 37.3% |
| 2019-03-31 | 2019-05-09 | $3.89 million | -$1.05 | -$1.06 | 1.32% |
| 2018-12-31 | 2019-02-28 | $3.74 million | -$1.03 | -$0.91 | -13.81% |
| 2018-09-30 | 2018-11-08 | $4.29 million | -$0.87 | -$1.02 | 14.29% |
| 2018-06-30 | 2018-08-08 | $3.22 million | -$1.30 | -$0.88 | -47.73% |
| 2018-03-31 | 2018-05-07 | $3.57 million | -$0.80 | -$0.76 | -5.72% |
| 2017-12-31 | 2018-03-08 | $3.32 million | -$0.11 | -$0.81 | 86.36% |
| 2017-09-30 | 2017-11-01 | $2.66 million | -$0.71 | -$0.88 | 19.32% |
| 2017-06-30 | 2017-08-09 | $2.36 million | -$0.78 | -$0.79 | 1.27% |
| 2017-03-31 | 2017-05-08 | $684000 | -$0.81 | -$0.03 | -2600% |
| 2016-12-31 | 2017-03-02 | $N/A | -$0.67 | -$0.67 | 0% |
| 2016-09-30 | 2016-11-09 | $N/A | -$0.67 | -$0.67 | 0% |
| 2016-06-30 | 2016-08-09 | $N/A | -$0.59 | ||
| 2016-03-31 | 2016-05-11 | $N/A | -$0.64 | ||
| 2015-12-31 | 2016-03-11 | $N/A | -$0.45 | ||
| 2015-09-30 | 2015-11-09 | $N/A | -$0.38 | ||
| 2015-06-30 | 2015-08-13 | $N/A | -$0.41 | ||
| 2015-03-31 | 2015-05-08 | $N/A | -$0.64 | ||
| 2014-12-31 | 2015-03-12 | $N/A | -$0.38 | -$0.57 | 33.33% |
| 2014-09-30 | 2014-11-17 | $N/A | -$1.33 | -$0.48 | -177.08% |
| 2014-06-30 | 2014-08-14 | $N/A | -$0.52 | -$0.65 | 20% |
| 2014-03-31 | 2014-04-02 | $N/A | -$1.45 | -$1.40 | -3.57% |
| 2013-09-30 | 2013-11-12 | $N/A | -$1.25 | -$1.30 | 3.85% |
| 2013-06-30 | 2013-08-09 | $N/A | -$1.20 | -$1.00 | -20% |
| 2013-03-31 | 2013-05-10 | $N/A | -$1.10 | -$1.10 | 0% |
| 2012-12-31 | 2013-03-18 | $N/A | -$1.40 | -$1.54 | 9.09% |
| 2012-09-30 | 2012-11-13 | $N/A | -$2.05 | -$1.94 | -5.67% |
| 2012-06-30 | 2012-08-09 | $N/A | -$2.95 | -$2.89 | -2.08% |
| 2012-03-31 | 2012-05-07 | $N/A | -$3.30 | -$2.51 | -31.47% |
| 2011-12-31 | 2012-03-14 | $N/A | -$8.90 | -$5.42 | -64.21% |
| 2011-09-30 | 2011-11-14 | $N/A | -$2.50 | -$2.50 | 0% |
| 2011-06-30 | 2011-08-15 | $N/A | -$4.85 | -$2.55 | -90.2% |
| 2011-03-31 | 2011-05-16 | $N/A | -$1.90 | -$0.87 | -118.39% |
| 2010-12-31 | 2011-03-02 | $N/A | -$118.00 |
Assembly Biosciences, Inc (ASMB) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Assembly Biosciences, Inc (ASMB) Chart:
Assembly Biosciences, Inc (ASMB) News:
Below you will find a list of latest news for Assembly Biosciences, Inc (ASMB) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Assembly Biosciences, Inc (ASMB) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 0.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 1 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 1.5 | 0.12 | CALL | 5 | 5 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 2 | 0.05 | CALL | 10 | 20 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 2.5 | 0.05 | CALL | 110 | 268 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 0.05 | CALL | 1 | 44 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.1 | CALL | 0 | 10 | 0 | TRUE | 0 | 0 |
| 2024-05-17 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 1.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 1.5 | PUT | 0 | 50 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0 | PUT | 0 | 0 | 210.55 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 0 | PUT | 0 | 0 | 223.43 | FALSE | 0 | 0 |
| 2024-08-16 | 0.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 1 | 0.25 | CALL | 7 | 3 | 160.41 | TRUE | 0 | 0.8 |
| 2024-08-16 | 1.5 | 0.32 | CALL | 0 | 1 | 130.07 | TRUE | 0 | 0 |
| 2024-08-16 | 2 | 0.28 | CALL | 2 | 5 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 0.1 | CALL | 10 | 10 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | CALL | 0 | 0 | 0 | TRUE | 0 | 0 |
| 2024-08-16 | 0.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 1.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0 | PUT | 0 | 0 | 144.84 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 0 | PUT | 0 | 0 | 176.93 | FALSE | 0 | 0 |
Latest ASMB Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:48 PM EST | 22 | $1.945 |
| Jun 13, 2022 7:48 PM EST | 28 | $1.945 |
| Jun 13, 2022 7:49 PM EST | 100 | $1.945 |
| Jun 13, 2022 7:52 PM EST | 100 | $1.945 |
| Jun 13, 2022 7:53 PM EST | 100 | $1.945 |
Assembly Biosciences, Inc (ASMB) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020029795/0001564590-20-029795-index.htm |
| 2020-09-02 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1426800/000000000020008294/0000000000-20-008294-index.htm |
| 2019-01-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000005341719000016/0000053417-19-000016-index.htm |
| 2019-05-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000005341719000084/0000053417-19-000084-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000005341720000029/0000053417-20-000029-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000021545719003199/0000215457-19-003199-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000083423720004662/0000834237-20-004662-index.htm |
| 2019-02-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000090221919000147/0000902219-19-000147-index.htm |
| 2020-01-08 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000090221920000041/0000902219-20-000041-index.htm |
| 2019-04-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000091957419003032/0000919574-19-003032-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000091957420001436/0000919574-20-001436-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000093583619000118/0000935836-19-000118-index.htm |
| 2019-05-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000093583619000288/0000935836-19-000288-index.htm |
| 2019-12-23 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000093583619000669/0000935836-19-000669-index.htm |
| 2019-11-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1426800/000095012319010301/0000950123-19-010301-index.htm |
| 2019-11-07 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1426800/000095012319010303/0000950123-19-010303-index.htm |
| 2020-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000108514620000756/0001085146-20-000756-index.htm |
| 2019-01-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000113777419000015/0001137774-19-000015-index.htm |
| 2019-04-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000113777419000061/0001137774-19-000061-index.htm |
| 2019-04-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000113777419000062/0001137774-19-000062-index.htm |
| 2020-02-03 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000113777420000021/0001137774-20-000021-index.htm |
| 2018-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418032466/0001144204-18-032466-index.htm |
| 2018-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418032468/0001144204-18-032468-index.htm |
| 2018-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418032469/0001144204-18-032469-index.htm |
| 2018-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418032470/0001144204-18-032470-index.htm |
| 2018-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418032472/0001144204-18-032472-index.htm |
| 2018-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418032474/0001144204-18-032474-index.htm |
| 2018-06-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418032476/0001144204-18-032476-index.htm |
| 2018-06-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420418034900/0001144204-18-034900-index.htm |
| 2018-07-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418037217/0001144204-18-037217-index.htm |
| 2018-07-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420418037690/0001144204-18-037690-index.htm |
| 2018-07-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1426800/000114420418038336/0001144204-18-038336-index.htm |
| 2018-07-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420418038525/0001144204-18-038525-index.htm |
| 2018-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418039136/0001144204-18-039136-index.htm |
| 2018-07-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418039137/0001144204-18-039137-index.htm |
| 2018-07-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420418039140/0001144204-18-039140-index.htm |
| 2018-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420418042855/0001144204-18-042855-index.htm |
| 2018-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1426800/000114420418042893/0001144204-18-042893-index.htm |
| 2018-08-08 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1426800/000114420418042894/0001144204-18-042894-index.htm |
| 2018-09-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418048565/0001144204-18-048565-index.htm |
| 2018-10-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420418053659/0001144204-18-053659-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420418058117/0001144204-18-058117-index.htm |
| 2018-11-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1426800/000114420418058118/0001144204-18-058118-index.htm |
| 2018-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418061513/0001144204-18-061513-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418064668/0001144204-18-064668-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418064669/0001144204-18-064669-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420418064671/0001144204-18-064671-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420419011356/0001144204-19-011356-index.htm |
| 2019-02-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1426800/000114420419011361/0001144204-19-011361-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419017733/0001144204-19-017733-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419017736/0001144204-19-017736-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419017740/0001144204-19-017740-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419017748/0001144204-19-017748-index.htm |
| 2019-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419017753/0001144204-19-017753-index.htm |
| 2019-04-04 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1426800/000114420419018190/0001144204-19-018190-index.htm |
| 2019-04-04 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1426800/000114420419018198/0001144204-19-018198-index.htm |
| 2019-04-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420419020592/0001144204-19-020592-index.htm |
| 2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420419023321/0001144204-19-023321-index.htm |
| 2019-05-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420419024898/0001144204-19-024898-index.htm |
| 2019-05-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1426800/000114420419024904/0001144204-19-024904-index.htm |
| 2019-05-09 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419024908/0001144204-19-024908-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419027155/0001144204-19-027155-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419027156/0001144204-19-027156-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419027157/0001144204-19-027157-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419027158/0001144204-19-027158-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419027159/0001144204-19-027159-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419027160/0001144204-19-027160-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419027161/0001144204-19-027161-index.htm |
| 2019-05-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419027162/0001144204-19-027162-index.htm |
| 2019-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420419027502/0001144204-19-027502-index.htm |
| 2019-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420419037651/0001144204-19-037651-index.htm |
| 2019-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1426800/000114420419037687/0001144204-19-037687-index.htm |
| 2019-08-05 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1426800/000114420419037697/0001144204-19-037697-index.htm |
| 2019-08-08 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419038642/0001144204-19-038642-index.htm |
| 2019-08-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000114420419038644/0001144204-19-038644-index.htm |
| 2019-08-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000114420419038915/0001144204-19-038915-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000117266119000428/0001172661-19-000428-index.htm |
| 2019-10-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000117266119001984/0001172661-19-001984-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000117266120000736/0001172661-20-000736-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000119312519290108/0001193125-19-290108-index.htm |
| 2019-12-11 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1426800/000119312519311678/0001193125-19-311678-index.htm |
| 2019-12-13 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1426800/000119312519313984/0001193125-19-313984-index.htm |
| 2019-12-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000119312519315242/0001193125-19-315242-index.htm |
| 2020-08-28 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1426800/000119312520234664/0001193125-20-234664-index.htm |
| 2020-09-03 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1426800/000119312520238947/0001193125-20-238947-index.htm |
| 2019-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919119051355/0001209191-19-051355-index.htm |
| 2019-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919119051359/0001209191-19-051359-index.htm |
| 2019-10-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919119051378/0001209191-19-051378-index.htm |
| 2019-10-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919119054272/0001209191-19-054272-index.htm |
| 2019-10-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919119054274/0001209191-19-054274-index.htm |
| 2019-11-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919119055720/0001209191-19-055720-index.htm |
| 2019-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919119055724/0001209191-19-055724-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/0001209191-19-060710-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919119060715/0001209191-19-060715-index.htm |
| 2020-01-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120001149/0001209191-20-001149-index.htm |
| 2020-03-30 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021707/0001209191-20-021707-index.htm |
| 2020-03-30 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021709/0001209191-20-021709-index.htm |
| 2020-03-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021796/0001209191-20-021796-index.htm |
| 2020-03-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021797/0001209191-20-021797-index.htm |
| 2020-03-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/0001209191-20-021798-index.htm |
| 2020-03-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021800/0001209191-20-021800-index.htm |
| 2020-05-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120032892/0001209191-20-032892-index.htm |
| 2020-05-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120032903/0001209191-20-032903-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120036627/0001209191-20-036627-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120036630/0001209191-20-036630-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120036632/0001209191-20-036632-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120036636/0001209191-20-036636-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120036637/0001209191-20-036637-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120036640/0001209191-20-036640-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120036642/0001209191-20-036642-index.htm |
| 2020-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120045952/0001209191-20-045952-index.htm |
| 2020-10-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120055488/0001209191-20-055488-index.htm |
| 2020-10-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1426800/000120919120055491/0001209191-20-055491-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1426800/000149315219001848/0001493152-19-001848-index.htm |
| 2019-10-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459019038136/0001564590-19-038136-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459019041796/0001564590-19-041796-index.htm |
| 2020-01-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020000214/0001564590-20-000214-index.htm |
| 2020-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020004234/0001564590-20-004234-index.htm |
| 2020-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020008685/0001564590-20-008685-index.htm |
| 2020-03-04 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1426800/000156459020008696/0001564590-20-008696-index.htm |
| 2020-04-16 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1426800/000156459020017065/0001564590-20-017065-index.htm |
| 2020-04-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1426800/000156459020018818/0001564590-20-018818-index.htm |
| 2020-04-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1426800/000156459020018827/0001564590-20-018827-index.htm |
| 2020-05-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020022900/0001564590-20-022900-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1426800/000156459020023566/0001564590-20-023566-index.htm |
| 2020-05-19 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1426800/000156459020026175/0001564590-20-026175-index.htm |
| 2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020029542/0001564590-20-029542-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020029795/0001564590-20-029795-index.htm |
| 2020-07-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020032666/0001564590-20-032666-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020036846/0001564590-20-036846-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1426800/000156459020036859/0001564590-20-036859-index.htm |
| 2020-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020041552/0001564590-20-041552-index.htm |
| 2020-08-28 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1426800/000156459020041777/0001564590-20-041777-index.htm |
| 2020-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020047123/0001564590-20-047123-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1426800/000156459020051400/0001564590-20-051400-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1426800/000156459020051470/0001564590-20-051470-index.htm |
| 2018-07-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1426800/000157104918000393/0001571049-18-000393-index.htm |
| 2020-09-04 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1426800/999999999520002378/9999999995-20-002378-index.htm |
| 2020-02-11 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1426800/999999999720000630/9999999997-20-000630-index.htm |
| 2020-02-26 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1426800/999999999720001013/9999999997-20-001013-index.htm |
Assembly Biosciences, Inc (ASMB) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Assembly Biosciences, Inc (ASMB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 465%Institutional Ownership: 9426%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-12-12 | GRAHAM K COOPER | Officer | Buy | 100,000.00 | 100,000.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418064668/0001144204-18-064668-index.htm | ||
| 2019-08-06 | John G McHutchison | CEO and President | Buy | 100,000.00 | 100,000.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420419038644/0001144204-19-038644-index.htm | ||
| 2018-12-12 | Jacqueline Sybil Papkoff | Officer | Buy | 10,625.00 | 10,625.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418064671/0001144204-18-064671-index.htm | ||
| 2018-12-12 | Richard James Colonno | Officer | Buy | 20,000.00 | 110,000.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418064669/0001144204-18-064669-index.htm | ||
| 2019-03-29 | GRAHAM K COOPER | Officer | Buy | 17,500.00 | 117,500.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420419017736/0001144204-19-017736-index.htm | ||
| 2019-11-06 | Luisa M Stamm | Chief Medical Officer | Buy | 12,000.00 | 12,000.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919119055724/0001209191-19-055724-index.htm | ||
| 2019-03-29 | Richard James Colonno | Officer | Buy | 16,250.00 | 126,250.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420419017740/0001144204-19-017740-index.htm | ||
| 2019-12-12 | Richard James Colonno | EVP & CSO, Virology Ops | Sell | 33,061.00 | 25.00 | 826,577.90 | 127,821.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/0001209191-19-060710-index.htm |
| 2020-03-31 | Richard James Colonno | EVP & CSO, Virology Ops | Sell | 7,812.00 | 15.04 | 117,523.73 | 137,009.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/0001209191-20-021798-index.htm |
| 2020-08-07 | John G McHutchison | CEO and President | Sell | 756.00 | 22.50 | 17,009.62 | 137,849.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919120045952/0001209191-20-045952-index.htm |
| 2020-08-07 | John G McHutchison | CEO and President | Sell | 11,395.00 | 21.76 | 247,907.34 | 138,605.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919120045952/0001209191-20-045952-index.htm |
| 2020-03-27 | Richard James Colonno | EVP & CSO, Virology Ops | Buy | 17,000.00 | 144,821.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/0001209191-20-021798-index.htm | ||
| 2020-03-27 | John G McHutchison | CEO and President | Buy | 50,000.00 | 150,000.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021796/0001209191-20-021796-index.htm | ||
| 2019-12-12 | Richard James Colonno | EVP & CSO, Virology Ops | Buy | 33,061.00 | 7.03 | 232,418.83 | 160,882.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/0001209191-19-060710-index.htm |
| 2018-06-01 | WILLIAM R RINGO | Director | Sell | 1,000.00 | 42.47 | 42,470.00 | 19,465.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418032476/0001144204-18-032476-index.htm |
| 2018-07-02 | WILLIAM R RINGO | Director | Sell | 1,000.00 | 38.50 | 38,503.00 | 19,465.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418037217/0001144204-18-037217-index.htm |
| 2019-10-01 | Michael P. Samar | SVP, Finance and Bus. Ops, PAO | Buy | 2,500.00 | 20,327.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919119051378/0001209191-19-051378-index.htm | ||
| 2018-06-01 | WILLIAM R RINGO | Director | Buy | 1,000.00 | 7.20 | 7,200.00 | 20,465.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418032476/0001144204-18-032476-index.htm |
| 2018-07-02 | WILLIAM R RINGO | Director | Buy | 1,000.00 | 7.20 | 7,200.00 | 20,465.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418037217/0001144204-18-037217-index.htm |
| 2019-12-13 | Jacqueline Sybil Papkoff | SVP-CSO Microbiome | Sell | 1,460.00 | 21.00 | 30,661.61 | 22,915.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919119060715/0001209191-19-060715-index.htm |
| 2019-03-29 | Jacqueline Sybil Papkoff | Officer | Buy | 13,750.00 | 24,375.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420419017753/0001144204-19-017753-index.htm | ||
| 2020-03-30 | Jacqueline Sybil Papkoff | SVP-CSO Microbiome | Sell | 1,254.00 | 14.22 | 17,830.88 | 38,661.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021800/0001209191-20-021800-index.htm |
| 2020-03-27 | Jacqueline Sybil Papkoff | SVP-CSO Microbiome | Buy | 17,000.00 | 39,915.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021800/0001209191-20-021800-index.htm | ||
| 2020-03-27 | Thomas Joseph Russo | CFO | Buy | 43,383.00 | 43,383.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021797/0001209191-20-021797-index.htm | ||
| 2020-05-27 | William E IV Delaney | CSO, Virology | Buy | 45,000.00 | 45,000.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919120032903/0001209191-20-032903-index.htm | ||
| 2020-03-26 | Jason A Okazaki | Chief Legal & Business Officer | Buy | 50,000.00 | 52,500.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919120021709/0001209191-20-021709-index.htm | ||
| 2018-09-06 | Uri A Lopatin | Chief Med. Off., VP Res. Dev. | Sell | 336.00 | 40.01 | 13,442.02 | 613,611.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418048565/0001144204-18-048565-index.htm |
| 2018-09-05 | Uri A Lopatin | Chief Med. Off., VP Res. Dev. | Sell | 15,204.00 | 40.09 | 609,546.60 | 613,947.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418048565/0001144204-18-048565-index.htm |
| 2019-03-29 | Uri A Lopatin | Chief Medical Officer | Buy | 13,750.00 | 627,361.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420419017748/0001144204-19-017748-index.htm | ||
| 2018-07-20 | Richard James Colonno | Officer | Buy | 25,000.00 | 65,000.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418039137/0001144204-18-039137-index.htm | ||
| 2018-07-19 | Derek A Small | CEO and President | Buy | 1,200.00 | 41.19 | 49,428.24 | 668,091.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418039136/0001144204-18-039136-index.htm |
| 2018-07-19 | Derek A Small | CEO and President | Buy | 1,200.00 | 41.77 | 50,123.04 | 669,291.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418039136/0001144204-18-039136-index.htm |
| 2019-03-29 | Derek A Small | CEO and President | Buy | 32,500.00 | 701,791.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420419017733/0001144204-19-017733-index.htm | ||
| 2020-01-02 | Derek A Small | Director | Buy | 125,000.00 | 828,791.00 | https://www.sec.gov/Archives/edgar/data/1426800/000120919120001149/0001209191-20-001149-index.htm | ||
| 2018-11-23 | Richard James Colonno | Officer | Buy | 25,000.00 | 90,000.00 | https://www.sec.gov/Archives/edgar/data/1426800/000114420418061513/0001144204-18-061513-index.htm |